MARKET INTRODUCTION
Point of care infectious disease are defined as the diagnostic services and products that are utilized for the detection and confirmation of infectious disease and disorders in patients that provide the outcomes in a significantly lesser time period and in close quarters to the care provision services to the patient. Point of care activities are performed in relatively quick time which can lead to change in patient management.
MARKET DYNAMICS
The key market drivers for Point of Care Infectious Disease Market Includes, increasing prevalence of infectious diseases globally along with rising demand of point of care systems in developing countries due to poor healthcare infrastructure. Whereas, strict regulatory approval for point of care infectious disease testing may expected to restrain market growth during the forecast period.
MARKET SCOPE
The "Point of Care Infectious Disease Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Point of Care Infectious Disease market with detailed market segmentation by technology offering, clinical applications and end user. The Point of Care Infectious Disease Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Point of Care Infectious Disease Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Point of Care Infectious Disease Market is segmented on the basis of technology offering, clinical applications and end user. On the basis of technology offering the market is segmented as, solid phase, lateral flow, agglutination assays and flow through. On the basis of clinical applications the market is segmented as, inflammatory diseases, liver disorders, HIV, respiratory disorders, hospital acquired infections, STDs and others. And on the basis of end user the market is segmented as, hospitals, home care, clinics, diagnostic centers and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Point of Care Infectious Disease Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Point of Care Infectious Disease Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Point of Care Infectious Disease Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Point of Care Infectious Disease Market in these regions.
MARKET PLAYERS
The report covers key developments in the Point of Care Infectious Disease Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Point of Care Infectious Disease Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Point of Care Infectious Disease market in the global market. Below mentioned is the list of few companies engaged in the Point of Care Infectious Disease Market.
The report also includes the profiles of key players in Point of Care Infectious Disease Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Danaher
- Abbott
- F. Hoffmann-La Roche Ltd
- BD
- Trinity Biotech Ireland
- AccuBio Tech Co.,Ltd
- Cardinal Health
- Thermo Fisher Scientific
- Meridian Bioscience, Inc
- MedMira Inc
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Point Of Care Infectious Disease Market - By Technology Offering
1.3.2 Point Of Care Infectious Disease Market - By Clinical Applications
1.3.3 Point Of Care Infectious Disease Market - By End User
1.3.4 Point Of Care Infectious Disease Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. POINT OF CARE INFECTIOUS DISEASE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. POINT OF CARE INFECTIOUS DISEASE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. POINT OF CARE INFECTIOUS DISEASE MARKET - GLOBAL MARKET ANALYSIS
6.1. POINT OF CARE INFECTIOUS DISEASE - GLOBAL MARKET OVERVIEW
6.2. POINT OF CARE INFECTIOUS DISEASE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. POINT OF CARE INFECTIOUS DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY OFFERING
7.1. OVERVIEW
7.2. TECHNOLOGY OFFERING MARKET FORECASTS AND ANALYSIS
7.3. SOLID PHASE
7.3.1. Overview
7.3.2. Solid Phase Market Forecast and Analysis
7.4. LATERAL FLOW
7.4.1. Overview
7.4.2. Lateral Flow Market Forecast and Analysis
7.5. AGGLUTINATION ASSAYS
7.5.1. Overview
7.5.2. Agglutination Assays Market Forecast and Analysis
7.6. FLOW-THROUGH
7.6.1. Overview
7.6.2. Flow-Through Market Forecast and Analysis
8. POINT OF CARE INFECTIOUS DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - CLINICAL APPLICATIONS
8.1. OVERVIEW
8.2. CLINICAL APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. TROPICAL DISEASES
8.3.1. Overview
8.3.2. Tropical Diseases Market Forecast and Analysis
8.4. INFLAMMATORY DISEASES
8.4.1. Overview
8.4.2. Inflammatory Diseases Market Forecast and Analysis
8.5. LIVER DISORDERS
8.5.1. Overview
8.5.2. Liver Disorders Market Forecast and Analysis
8.6. HIV
8.6.1. Overview
8.6.2. HIV Market Forecast and Analysis
8.7. RESPIRATORY DISORDERS
8.7.1. Overview
8.7.2. Respiratory Disorders Market Forecast and Analysis
8.8. HOSPITAL ACQUIRED INFECTIONS
8.8.1. Overview
8.8.2. Hospital acquired infections Market Forecast and Analysis
8.9. STDS
8.9.1. Overview
8.9.2. STDs Market Forecast and Analysis
8.10. OTHERS
8.10.1. Overview
8.10.2. Others Market Forecast and Analysis
9. POINT OF CARE INFECTIOUS DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. HOME-CARE
9.4.1. Overview
9.4.2. Home-Care Market Forecast and Analysis
9.5. CLINICS
9.5.1. Overview
9.5.2. Clinics Market Forecast and Analysis
9.6. DIAGNOSTIC CENTERS
9.6.1. Overview
9.6.2. Diagnostic Centers Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. POINT OF CARE INFECTIOUS DISEASE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Point Of Care Infectious Disease Market Overview
10.1.2 North America Point Of Care Infectious Disease Market Forecasts and Analysis
10.1.3 North America Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.1.4 North America Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.1.5 North America Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.1.6 North America Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.1.6.1 United States Point Of Care Infectious Disease Market
10.1.6.1.1 United States Point Of Care Infectious Disease Market by Technology Offering
10.1.6.1.2 United States Point Of Care Infectious Disease Market by Clinical Applications
10.1.6.1.3 United States Point Of Care Infectious Disease Market by End User
10.1.6.2 Canada Point Of Care Infectious Disease Market
10.1.6.2.1 Canada Point Of Care Infectious Disease Market by Technology Offering
10.1.6.2.2 Canada Point Of Care Infectious Disease Market by Clinical Applications
10.1.6.2.3 Canada Point Of Care Infectious Disease Market by End User
10.1.6.3 Mexico Point Of Care Infectious Disease Market
10.1.6.3.1 Mexico Point Of Care Infectious Disease Market by Technology Offering
10.1.6.3.2 Mexico Point Of Care Infectious Disease Market by Clinical Applications
10.1.6.3.3 Mexico Point Of Care Infectious Disease Market by End User
10.2. EUROPE
10.2.1 Europe Point Of Care Infectious Disease Market Overview
10.2.2 Europe Point Of Care Infectious Disease Market Forecasts and Analysis
10.2.3 Europe Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.2.4 Europe Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.2.5 Europe Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.2.6 Europe Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Point Of Care Infectious Disease Market
10.2.6.1.1 Germany Point Of Care Infectious Disease Market by Technology Offering
10.2.6.1.2 Germany Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.1.3 Germany Point Of Care Infectious Disease Market by End User
10.2.6.2 France Point Of Care Infectious Disease Market
10.2.6.2.1 France Point Of Care Infectious Disease Market by Technology Offering
10.2.6.2.2 France Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.2.3 France Point Of Care Infectious Disease Market by End User
10.2.6.3 Italy Point Of Care Infectious Disease Market
10.2.6.3.1 Italy Point Of Care Infectious Disease Market by Technology Offering
10.2.6.3.2 Italy Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.3.3 Italy Point Of Care Infectious Disease Market by End User
10.2.6.4 Spain Point Of Care Infectious Disease Market
10.2.6.4.1 Spain Point Of Care Infectious Disease Market by Technology Offering
10.2.6.4.2 Spain Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.4.3 Spain Point Of Care Infectious Disease Market by End User
10.2.6.5 United Kingdom Point Of Care Infectious Disease Market
10.2.6.5.1 United Kingdom Point Of Care Infectious Disease Market by Technology Offering
10.2.6.5.2 United Kingdom Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.5.3 United Kingdom Point Of Care Infectious Disease Market by End User
10.2.6.6 Rest of Europe Point Of Care Infectious Disease Market
10.2.6.6.1 Rest of Europe Point Of Care Infectious Disease Market by Technology Offering
10.2.6.6.2 Rest of Europe Point Of Care Infectious Disease Market by Clinical Applications
10.2.6.6.3 Rest of Europe Point Of Care Infectious Disease Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Point Of Care Infectious Disease Market Overview
10.3.2 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis
10.3.3 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.3.4 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.3.5 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Point Of Care Infectious Disease Market
10.3.6.1.1 Australia Point Of Care Infectious Disease Market by Technology Offering
10.3.6.1.2 Australia Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.1.3 Australia Point Of Care Infectious Disease Market by End User
10.3.6.2 China Point Of Care Infectious Disease Market
10.3.6.2.1 China Point Of Care Infectious Disease Market by Technology Offering
10.3.6.2.2 China Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.2.3 China Point Of Care Infectious Disease Market by End User
10.3.6.3 India Point Of Care Infectious Disease Market
10.3.6.3.1 India Point Of Care Infectious Disease Market by Technology Offering
10.3.6.3.2 India Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.3.3 India Point Of Care Infectious Disease Market by End User
10.3.6.4 Japan Point Of Care Infectious Disease Market
10.3.6.4.1 Japan Point Of Care Infectious Disease Market by Technology Offering
10.3.6.4.2 Japan Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.4.3 Japan Point Of Care Infectious Disease Market by End User
10.3.6.5 South Korea Point Of Care Infectious Disease Market
10.3.6.5.1 South Korea Point Of Care Infectious Disease Market by Technology Offering
10.3.6.5.2 South Korea Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.5.3 South Korea Point Of Care Infectious Disease Market by End User
10.3.6.6 Rest of Asia-Pacific Point Of Care Infectious Disease Market
10.3.6.6.1 Rest of Asia-Pacific Point Of Care Infectious Disease Market by Technology Offering
10.3.6.6.2 Rest of Asia-Pacific Point Of Care Infectious Disease Market by Clinical Applications
10.3.6.6.3 Rest of Asia-Pacific Point Of Care Infectious Disease Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Point Of Care Infectious Disease Market Overview
10.4.2 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis
10.4.3 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.4.4 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.4.5 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Point Of Care Infectious Disease Market
10.4.6.1.1 South Africa Point Of Care Infectious Disease Market by Technology Offering
10.4.6.1.2 South Africa Point Of Care Infectious Disease Market by Clinical Applications
10.4.6.1.3 South Africa Point Of Care Infectious Disease Market by End User
10.4.6.2 Saudi Arabia Point Of Care Infectious Disease Market
10.4.6.2.1 Saudi Arabia Point Of Care Infectious Disease Market by Technology Offering
10.4.6.2.2 Saudi Arabia Point Of Care Infectious Disease Market by Clinical Applications
10.4.6.2.3 Saudi Arabia Point Of Care Infectious Disease Market by End User
10.4.6.3 U.A.E Point Of Care Infectious Disease Market
10.4.6.3.1 U.A.E Point Of Care Infectious Disease Market by Technology Offering
10.4.6.3.2 U.A.E Point Of Care Infectious Disease Market by Clinical Applications
10.4.6.3.3 U.A.E Point Of Care Infectious Disease Market by End User
10.4.6.4 Rest of Middle East and Africa Point Of Care Infectious Disease Market
10.4.6.4.1 Rest of Middle East and Africa Point Of Care Infectious Disease Market by Technology Offering
10.4.6.4.2 Rest of Middle East and Africa Point Of Care Infectious Disease Market by Clinical Applications
10.4.6.4.3 Rest of Middle East and Africa Point Of Care Infectious Disease Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Point Of Care Infectious Disease Market Overview
10.5.2 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis
10.5.3 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis - By Technology Offering
10.5.4 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis - By Clinical Applications
10.5.5 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis - By End User
10.5.6 South and Central America Point Of Care Infectious Disease Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Point Of Care Infectious Disease Market
10.5.6.1.1 Brazil Point Of Care Infectious Disease Market by Technology Offering
10.5.6.1.2 Brazil Point Of Care Infectious Disease Market by Clinical Applications
10.5.6.1.3 Brazil Point Of Care Infectious Disease Market by End User
10.5.6.2 Argentina Point Of Care Infectious Disease Market
10.5.6.2.1 Argentina Point Of Care Infectious Disease Market by Technology Offering
10.5.6.2.2 Argentina Point Of Care Infectious Disease Market by Clinical Applications
10.5.6.2.3 Argentina Point Of Care Infectious Disease Market by End User
10.5.6.3 Rest of South and Central America Point Of Care Infectious Disease Market
10.5.6.3.1 Rest of South and Central America Point Of Care Infectious Disease Market by Technology Offering
10.5.6.3.2 Rest of South and Central America Point Of Care Infectious Disease Market by Clinical Applications
10.5.6.3.3 Rest of South and Central America Point Of Care Infectious Disease Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. POINT OF CARE INFECTIOUS DISEASE MARKET, KEY COMPANY PROFILES
12.1. DANAHER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. TRINITY BIOTECH IRELAND
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ACCUBIOTECH CO., LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CARDINAL HEALTH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. THERMO FISHER SCIENTIFIC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERIDIAN BIOSCIENCE, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MEDMIRA INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Danaher
2. Abbott
3. F. Hoffmann-La Roche Ltd
4. BD
5. Trinity Biotech Ireland
6. AccuBioTech Co., Ltd.
7. Cardinal Health
8. Thermo Fisher Scientific
9. Meridian Bioscience, Inc
10. MedMira Inc
Global Loop-mediated Isothermal Amplific..
According to this latest study, the 2020 growth of Loop-medi..
+1-646-791 7070US (Toll Free)